Octreotide Long-Acting ReleaseTherapy for Patients with Functional and Metastatic Gastroenteropancreatic Neuroendocrine Tumors: A Retrospective Analysis in Chang-Gung Memorial Hospital
#458
Introduction: Reports of octreotide therapy for symptomatic control in patients with functioning gastroenteropancreatic neuroendocrine tumors (GEP-NETs) in Asia are lacking.
Aim(s): To assess the efficacy of Octreotide therapy in patients with functioning GEP-NETs in the Asian population.
Materials and methods: Functioning GEP-NET patients who underwent Octreotide long-acting release (LAR) during June, 2002 to December, 2011 in Chang-Gung Memorial hospital (CGMH) were retrospectively analyzed.
Conference: 9th Annual ENETSConcerence (2012)
Presenting Author:
Authors: Chia-Hsun H, Wen-Chi C, Yung-Chang L, Chaung-Chi L, Rong-Nan C,
Keywords: functioning gastroenteropancreatic neuroendocrine tumors, Octreotide LAR ,
To read the full abstract, please log into your ENETS Member account.